Therapeutic Asset Ratings
1,553 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
HIGH OLEIC SOYBEAN OIL (UNHYDROGENATED)
Obesity Disorder
University of Oklahoma
Early P1
C
(39)
hnf4α srrna
Colorectal Cancer
Shanghai Changzheng Hospital
Early P1
C
(39)
Human Amniotic-Derived Mesenchymal Stem Cells
Calciphylaxis
The First Affiliated Hospital with Nanjing Medical University
Early P1
C
(39)
Human Amniotic-Derived Mesenchymal Stem Cells
Chronic Kidney Disease
The First Affiliated Hospital with Nanjing Medical University
Early P1
C
(39)
Humanized Cd19 Car-T Cells
B-Cell Acute Lymphoblastic Leukemia
Zhujiang Hospital
Early P1
C
(39)
Humanized Cd19 Car-T Cells
B-Cell Non-Hodgkin Lymphoma
Zhejiang University
Early P1
C
(39)
Humulin R
Autonomic Dysfunction
University of Missouri-Columbia
Early P1
C
(39)
Humulin R
Vasodilation
University of Missouri-Columbia
Early P1
C
(39)
Hyaluronidase
Neuralgia
Minia University
Early P1
C
(39)
Hyaluronidase fihj
Adult Acute Lymphoblastic Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early P1
C
(39)
Hyaluronidase fihj
Aplastic Anemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early P1
C
(39)
Hyaluronidase fihj
Transplant Rejection
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early P1
C
(39)
Hyaluronidase fihj
Myelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early P1
C
(39)
Hyaluronidase zzxf
Ovarian Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Hyaluronidase zzxf
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Hyaluronidase zzxf
Prostate Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Hyaluronidase zzxf
Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Hyaluronidase zzxf
Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Hyaluronidase zzxf
Ovarian Cancer
OHSU Knight Cancer Institute
Early P1
C
(39)
Hydrochlorothiazide
SCS
University of Kansas Medical Center
Early P1
C
(39)
Hyoscine
Auditory Perceptual Disorders
Yale University
Early P1
C
(39)
Iaso104
Plasma Cell Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Early P1
C
(39)
Iaso104
Plasma Cell Myeloma
Institute of Hematology & Blood Diseases Hospital, China
Early P1
C
(39)
IBI311
Prostate Cancer
Shanghai Changzheng Hospital
Early P1
C
(39)
ibr900 cell
Lymphoma
Beijing Boren Hospital
Early P1
C
(39)
Showing 526 to 550 of 1,553 assets
Previous
Page 22 of 63
Next
